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energy,[6] automotive, and biology, in par-
ticular cellular cryopreservation[7–10]; the 
storage of cells/tissues at sub-zero tem-
peratures, which underpins many areas 
of modern biomedicine, clinical medicine, 
and basic biology. Current strategies are 
based on adding large volumes of (low 
molecular weight) cryoprotective agents 
such as glycerol or DMSO which enable 
slow freezing or vitrification.[11–13] Anti-
freeze (glyco) proteins, (AF(G)Ps) have 
been found to improve cryopreservation 
outcomes, due to their property of ice 
recrystallization inhibition (IRI; discussed 
more below),[14–16] but also potentially by 
stabilizing membranes.[17,18] Considering 
this, there has been significant recent 
interest in developing synthetic materials 
to mimic AF(G)Ps. AF(G)Ps have three 
main properties resulting from their ice 
interactions; non-colligative depression 
of the freezing point (thermal hysteresis 
(TH)), dynamic ice shaping (DIS); IRI 
activity. The latter (IRI) is of particular 
interest, as it was discovered in 2003 that synthetic mimics of 
AFGPs can retain IRI activity,[19] but not thermal hysteresis or 
DIS, even after major structural modifications, suggesting this 
property may be easier to mimic (as it may not require ice-face 
binding) and it has application in cryopreservation.[20–23] What 
is clear, however, is that the synthetic mimics tend to be far less 
active than the natural antifreezes, yet the activity appears to 
be sufficient to enable beneficial cryopreservation outcomes.[22] 
In short, it might not be that the most active IRI material is 
the most useful (e.g., depending on how accessible it is) and 
recent results suggest that IRI activity can be induced by more 
than one mechanism, including those which do not include ice 
binding.[4,24]
Considering the interest in introducing IRI activity into syn-
thetic materials, the aim of this article is to provide a concise 
comparison of the IRI activities of a range of biological and 
synthetic compounds. Here we use the “splat” assay, which 
is a common and easily accessible technique to evaluate IRI 
activity, but by no means the only method. We also summarize 
the currently known materials with IRI, providing a snapshot 
of the emerging field. Based on this, we also propose a “rough 
guide to activity,” grouping materials from potent to very weak 
activity to enable researchers to decide if a new material is 
active or not, relative to those already published and especially 
Antifreeze Mimetic Polymers
Antifreeze proteins and ice-binding proteins have been discovered in a 
diverse range of extremophiles and have the ability to modulate the growth 
and formation of ice crystals. Considering the importance of cryoscience 
across transport, biomedicine, and climate science, there is significant 
interest in developing synthetic macromolecular mimics of antifreeze pro-
teins, in particular to reproduce their property of ice recrystallization inhibi-
tion (IRI). This activity is a continuum rather than an “on/off” property and 
there may be multiple molecular mechanisms which give rise to differences 
in this observable property; the limiting concentrations for ice growth vary 
by more than a thousand between an antifreeze glycoprotein and poly(vinyl 
alcohol), for example. The aim of this article is to provide a concise com-
parison of a range of natural and synthetic materials that are known to have 
IRI, thus providing a guide to see if a new synthetic mimic is active or not, 
including emerging materials which are comparatively weak compared to 
antifreeze proteins, but may have technological importance. The link between 
activity and the mechanisms involving either ice binding or amphiphilicity is 
discussed and known materials assigned into classes based on this.
1. Introduction
Antifreeze, ice-binding and ice-nucleating macromolecules 
have been discovered in a diverse range of extremophile 
organisms from fish to insects to plants. These are produced 
to enable the species to survive by promoting freeze-tolerance 
and freeze-avoidance and have been extensively reviewed.[1–4] 
The ability to modulate ice formation and growth has vast tech-
nological importance across fields such as aerospace,[5] green 
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for non-protein IRI active materials. It should be noted that 
Koop et al. have proposed a similar map based on growth rate 
constants, but only included highly active peptide (and PVA) 
ice growth inhibitors,[25] whereas we intend to include exam-
ples of, and activity data for, emerging materials at all activity 
levels.
2. Measuring IRI Activity
The first, and most widely used, method for measuring IRI 
is the “splat” assay as shown by Knight.[26] This assay enables 
quick assessment of IRI activity by monitoring the growth of 
ice grains that have been nucleated rapidly at low temperatures 
(≈−80 °C) to ensure only growth (not nucleation) events are 
probed. This is a kinetic assay, hence shorter time points will 
always give smaller crystals. It is essential to compare materials 
under similar conditions to allow reliable assessment of more/
less activity. In the present work, 30 min of annealing is used, 
as this is sufficient for screening, especially for identifying 
materials with lower or no activity, which quickly trend toward 
the control. More active IRIs (such as the antifreeze proteins) 
can inhibit ice growth for hours, but the majority of mimics are 
far less active than this, however all materials, no matter how 
active, will only slow ice growth, none can stop it completely. 
The temperature of the assay and the use of saline are also cru-
cial. There must be sufficient NaCl (or another salt) to ensure 
a eutectic phase such that there is liquid water between the 
boundaries.[26] False positives can occur when using pure water 
or too low saline, and hence even poly(ethylene glycol) (PEG) 
which is used as a negative control appears to inhibit recrystalli-
zation when conducted in water (see Supporting Information). 
The temperature is also crucial, with −6 to −8 °C often used, 
with lower temperatures potentially not allowing for recrystal-
lization and yielding false positives. Data from these assays 
are often reported as the mean largest grain size (MLGS) or 
mean grain size (MGS). MLGS reports the largest grain in the 
field of view, and hence is slightly biased toward lower activity 
(more growth) and is easy to measure without image analysis 
software. MGS reports the average grain size in the field but 
requires measurement or counting of all crystals. Figure 1 
shows example cryomicrographs of active (PVA) and inactive 
(PEG) polymers and shows the impact of conducting the assay 
in water, where a negative control can give the impression of 
activity. Ben et al. have reported domain recognition software 
to identify grain boundaries but it has not been widely used.[27] 
An adaptation of this method uses concentrated sucrose solu-
tions (>20 wt%) to generate isolated ice crystals. Due to the 
separation of crystals image analysis is facilitated. Using this 
method, Koop and co-workers have analyzed the kinetics of ice 
growth in the context of LSW theory to generate inhibition con-
stants,[25,28] but it is a slower method than the aforementioned 
“splat” assay, albeit one that provides detailed insight. Davies 
et al. have employed rapid freezing of capillaries to measure 
IRI, with the advantage that the samples can be stored for later 
use.[29] However, this method is well suited for potent IRI active 
materials that inhibit all growth (as it is an end-point assay), so 
it is not suitable for those materials with weak activity as dis-
cussed here.
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This article contains both new, and previously published IRI 
activity, focusing on that obtained by the “splat” assay where 
possible to allow critical comparison.
3. Proteins and Polymers Which Bind Ice
To demonstrate the large range of IRI activity between some 
commonly used macromolecular inhibitors, the concentration 
dependence on the MLGS for AFGP8, AFP type III (AFPIII), 
PVA, and PEG (as a negative/weakly active) control is plotted 
Macromol. Biosci. 2019, 1900082
Figure 1. Example cryomicrographs of “splat” tests. Images are after 
the indicated period of time, following annealing at − 8 °C. PBS con-
tains 0.137 m NaCl. PVA, poly(vinyl alcohol), Mn = 880 g mol−1; PEG, 
poly(ethylene glycol), Mn = 4000 g mol−1. Scale bar = 100 µm.
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in Figure 2. AFGP inhibits all growth at concentrations as low 
as 0.005 mg mL−1, but for PVA20 (one of the most active syn-
thetic mimics reported[4,24,30]) up to 1 mg mL−1 is required—
a 200-fold difference. The AFPIII (which is not glycosylated) 
showed activity between the two, inhibiting all growth at 
≈0.1 mg mL−1. This difference in activity highlights the 
remarkable properties of AF(G)Ps and the immense challenge 
of reproducing their function. PEG, which is not reported to 
have any ice-binding/interacting effects, cannot fully inhibit 
growth even at 100 mg mL−1. This not only shows the vast 
range of potential IRI activities, but also highlights the key 
challenge in the discovery of useful new materials in that any 
macromolecular material will slow ice growth if a sufficiently high 
concentration is added.
This small set alone shows the importance of screening 
with a negative control, such as PEG, as essentially any mate-
rial can claim to have IRI activity but the magnitude of this is 
the crucial parameter. A detailed discussion of AFGP/AFP’s 
high activity is beyond the scope of this feature article, but in 
both cases it appears to be due to specific recognition of the 
primary prism face of ice, which is the fastest growing face 
under standard conditions.[31] There is still uncertainty as to 
how exactly AFGPs bind ice though, either through their gly-
cans,[32] or the peptide backbone.[33] Hyperactive AFPs, which 
display a larger thermal hysteresis gap can also bind the basal 
face.[34,35] Experimental and modeling evidence supports PVA’s 
unique activity being due to its hydroxyls precisely matching 
the spacing on the prism plane of ice, and a balance of 
enthalpy/entropy compensation leads to increased affinity and 
hence inhibition[36–38] due to a multivalent or “zipper” effect 
(Figure 2C). This also explains why many other polyols fail 
to inhibit growth as they do not have this extended stretch of 
hydroxyls with precise spacing, with a range of glycopolymers 
or carbohydrates (see Supporting Information) showing very 
little activity.[39,40] The molecular weight dependence of PVA’s 
activity has been explored in detail previously, and is outside 
the scope of this article.[38,41] Polymer chain architecture has 
also shown to be important, with three-arm PVA demonstrating 
IRI activity equal to that of a linear polymer the same length as 
two of the arms.[42] It has been suggested that this is because of 
the inability of the third arm to effectively bind a basal plane of 
ice, as the other two arms (binding in a linear fashion) confine 
the third.[37]
4. Ice-Binding Self-Assembled Materials
The previous section summarizes the activity range of mate-
rials with characterized (or hypothesized) ice-binding inter-
actions. As an interesting example of unusual IRI active 
materials, Drori et al. showed that safranin-O (a dye) is a potent 
IRI (Figure 3).[43] Safranin-O has no obvious structural similari-
ties to AFPs but in aqueous solution self-assembles into fibers 
which can present a hydrophobic face that is similar to the 
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Figure 2. A) IRI activity of a range of highly active materials (PVA, AFPIII, 
AFGP) and PEG which is considered to be inactive. B) Structures of 
PVA, PEG, AFPIII, and AFGP. C) Proposed binding conformation for the 
adsorption of PVA onto the primary prism face (C), and secondary prism 
face (D). Reproduced with permission.[36] Copyright 2006, Wiley.
Figure 3. Supramolecular ice growth inhibitors. A) IRI comparison of 
ZrAc and safranin-O, B) Proposed ZrAc solution structure with ace-
tate face, and hydroxyl face.[45] C) Safranin-O self-assembly into fibers. 
Reprinted (adapted) with permission.[43] Copyright 2016, American 
Chemical Society.
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solution structure of some AFPs. Safranin-O can inhibit all ice 
growth at just 1 mg mL−1, similar to PVA. Addition of a phenyl 
group disrupts the self-assembly and turns off the activity, sup-
porting a mechanism where an extended hydrophobic face is 
essential.
In solution, zirconium acetate (ZrAc) can polymerize to 
form extended structures and it has been reported to have both 
ice shaping and IRI activity.[44,45] In solution, the structure of 
ZrAc produces a coordination polymer with regularly spaced 
hydroxyls and acetate groups, which could either hydrogen 
bond to ice (e.g., like PVA) or interact via hydrophobic interac-
tions (as with AFPs). Figure 3A shows ZrAc activity (note that 
this is relative to a pH 5 acetate buffer as it is not soluble in 
standard PBS) revealing it has similar activity to the AFP and 
safranin-O, inhibiting all growth below 1 mg mL−1. Other 
metal acetates, to the best of our knowledge, do not have this 
effect but it does support a hypothesis that the design of supra-
molecular IRIs is indeed possible, if not easy. There is also a 
report of graphene oxide inhibiting ice growth in this concen-
tration range (all growth stopped at 5 mg mL−1).[46] Graphene 
oxide is also known to affect ice nucleation[47,48]; such dual 
activity has also been observed for some AFPs.[49]
5. Facially Amphiphilic, Non-Ice-Binding Materials 
and Compounds
The previous examples are materials which have character-
ized ice-binding activity, either from direct measurements, or 
by observation of ice crystal shaping, and in most cases this 
affinity for the primary prism plane of ice is what drives their 
observable activity. In 2003, Ben et al. discovered that sim-
plification of the AFGP structure to present only α-galactose 
(in place of the native disaccharide) and replacing alanine 
with glycine resulted in peptides that had definite IRI but no 
thermal hysteresis.[19] This finding suggested that it was pos-
sible to achieve potent IRI, but without the need to target a 
specific plane of ice, that is, there are multiple molecular level 
mechanisms which can give rise to the same macroscopic effect. 
The same group has reported a series of modified glycopep-
tides with potent IRI, with the distance between backbone[50] 
and glycan being important as well as backbone hydropho-
bicity.[51,52] Figure 4A shows anchored clathrate water on the 
surface of an AFP, which directs the binding to multiple ice 
planes (basal and prism) due to crystallographic matches.[53] 
Figure 4B shows a simulation of spruce budworm AFP and 
its hypothesized binding to the prism plane via coordinated 
water molecules providing a match.[54] Whilst the molec-
ular binding details are still under investigation, there is 
overwhelming evidence for AFPs binding to ice faces and 
strong evidence of molecular level interactions have been 
determined.[34,55–59] However, for the facially amphipathic 
molecules, with no evidence for ice binding, an alterna-
tive molecular level mechanism which can give rise to IRI 
is required. One proposal is that these can sit at the semi-
ordered water layer (sometimes referred to as quasi-liquid 
layer, QLL, which is strictly a definition at surfaces)[60]/
bulk water interface, rather than directly interact with ice 
faces.[61,62] If the compounds can disorder this region, they 
will not fit well with bulk water, nor semi-ordered water later 
and hence the barrier to adding more water to the ice crystal 
is higher and slows recrystallization.[61]
Ben and co-workers synthesized a range of alkylated galac-
tose derivatives and assessed their IRI. Increasing the alkyl 
chain length from seven to nine carbon atoms lead to an 
increase in activity (Figure 5) until micellization occurred. 
Micellization buries the hydrophobic units in the core and 
hence only hydrophilic units are presented, highlighting the 
delicate balance required in this approach to induce IRI.[63] 
Lysine-based surfactants with increasing hydrophobic modi-
fications show increased IRI activity, and clearly have no 
ice-binding site. These carry a net charge confirming that a 
sugar unit is not an essential moiety for IRI.[64,65] It should 
be noted, however, that removing the glycan unit from an 
AFGP completely removes its ability to bind to ice effectively, 
as shown by Nishimura et al.,[66] which demonstrates that 
conclusions drawn for one class of IRI may not be valid for 
others.
To avoid the issue of aggregation upon sequential 
increases in hydrophobicity, Mitchell et al. exploited Nisin 
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Figure 4. Modes of action resulting in IRI (and in case of A/B ice 
shaping). A) Anchored clathrate water on the surface of an antifreeze 
protein (MpAFP_RIV). Adapted with permission.[53] Copyright 2011. 
National Academy of Sciences. B) Molecular dynamics results showing 
Spruce Budworm AFP with ordered water on AFP surface binding to the 
prism plane of ice. Reproduced with permission.[54] Copyright 2015, eLife 
Sciences Publications. C) Interruption of the bulk water/semi-ordered 
water interface. Reproduced with permission.[62] Copyright 2014, Royal 
Society of Chemistry. Note: QLL (quasi-liquid layer) is indicated in the 
reproduced figure, but the term semi-ordered layer is used here.
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A as a pH switchable IRI. Nisin A is 
an antimicrobial peptide that upon 
lowering the pH assumes a facially 
amphipathic structure, with segregated 
hydrophobic/hydrophilic domains.[67] 
Using the “splat” assay, Nisin shows 
IRI at low pH (or upon coordination of 
metal ions), which was erased at higher 
pHs. This provided more evidence for 
the hypothesis that the presentation of a 
spatially segregated hydrophobic face is 
crucial for activity. The actual IRI seen, 
however, was rather weak requiring 
5 mg mL−1 to inhibit 50% of ice growth. 
AFPs and AFGPs also show facial 
amphiphilicity[66,68] and simulations 
suggest this facial amphiphilicity is cru-
cial for AFGPs[33] but not necessarily for 
AFPs.[58,69] These experiments provided 
crucial data that a second structural 
feature, after ice binding, can be used 
to introduce IRI into a synthetic mate-
rial; spatially segregated hydrophobic/
hydrophilic domains, but without 
micellization. Mitchell et al. further 
used self-assembling metallohelices to 
probe this concept. The helices show 
patchy hydrophobicity and no obvious 
ice-binding sites, yet can inhibit ice growth completely at 
around 5 mg mL−1, making them one of the more potent 
synthetic inhibitors reported (Figure 6A,B). A key feature 
of AFGPs is that increasing their length (i.e., more tripep-
tide repeats) leads to more IRI (and TH) activity.[25] Hence, 
synthetic polymers, where the chain length is easily tuned, 
are appealing based on this design principle.[70] However, 
it is challenging to separate hydrophobic and hydrophilic 
domains when using conventional radical polymerization 
which gives flexible backbones. Tew et al. reported that using 
ROMP (ring opening metathesis polymerization) semi-rigid 
polymers can be obtained. ROMP-derived polymers have 
limited rotation due to the alkene (and often cycle) structure 
in the backbone, hence hydrophobic groups can be placed 
opposite hydrophilic, to install facial amphiphilicity.[71,72] 
Graham et al. synthesized ROMP glycopolymers bearing a 
galactose residue on one face, and either an oxo or a fulvo 
(more hydrophobic) residue on the opposing face. IRI assays 
showed that the fulvo polymers were far more active than 
oxo, confirming that the amphiphilicity rather than the pres-
ence of a glycan is the key structural feature.[73] It also sup-
ported the hypothesis that segregation of these groups is 
crucial. No ice shaping was seen for these materials, sug-
gesting no ice binding.
6. Flexible Polymers and Hydrophobicity
It is clear that correct 3D placement of hydrophobic groups 
can modulate IRI activity and may be crucial in natural 
Macromol. Biosci. 2019, 1900082
Figure 5. Glycomimetics of AFGPs. A) Structural simplifications to a 
glycopeptide with IRI but not thermal hysteresis activity. Reproduced 
with permission.[19] Copyright 2003, Springer Nature Switzerland AG. B) 
Impact of increased hydrophobic tail length on observable IRI. Repro-
duced with permission.[63] Copyright 2013, Royal Society of Chemistry.
Figure 6. Facially amphiphilic IRI active compounds. A) Self-assembled metallohelices. B) Charge 
distribution and hydrophobicity plots, colored according to scale. Reproduced with permission.[74] 
Copyright 2017, American Chemical Society. B) IRI active rigid glycopolymers (from ROMP) versus 
weakly active flexible glycopolymers (with saturated backbones).
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AF(G)Ps, in addition to their remarkable ice-binding prop-
erties.[2] However, in the case of synthetic polymers, most 
are flexible coils due to a saturated backbone with sp3 
bonding, and cannot present specific “patches” of hydro-
phobicity. There has been interest in the introduction of 
IRI activity into polymers based on the statistical incorpora-
tion of hydrophobic groups, which may offer a route to low-
cost IRI active materials. The most studied in this context 
are poly(ampholytes)—polymers bearing mixed positive and 
negative charges. Matsumura et al. reported that carboxyla-
tion of poly(ε-lysine), to give a 50:50 mix of charges, produced 
polymers that were potent cryopreservatives when used in 
conjugation with traditional cryoprotective agents.[75,76] Later 
studies showed that this ratio of charges was essential for 
both cryopreservation and for IRI activity.[77] Matsumura has 
investigated poly(ampholytes) derived from dimethylaminoe-
thyl methacrylate (DMAEMA) and methacrylic acid (MAA), 
which have some IRI activity as well as being effective cel-
lular cryoprotectants. Copolymers of DMAEMA and MAA 
achieved around 50% inhibition at 100 mg mL−1 (which is 
identical to PEG), however upon the incorporation of as little 
as 5% butyl methacrylate or octyl methacrylate into the chain, 
a MGS of 5% was observed at the same concentration, sug-
gesting an increase in activity Figure 7.[78] To study this in 
more detail, Stubbs et al. synthesized a panel of regioregular 
poly(ampholyte)s using maleic anhydride copolymers, which 
ensure an alternating, rather than random, copolymer struc-
ture. Sequential increases in hydrophobicity were introduced 
by ring opening of the anhydride using alcohols.[79] There was 
a clear trend that increased hydrophobicity increased the IRI 
activity. It is crucial to note here that the magnitude of activity 
is far less than the previous classes (AF(G)Ps/PVA) with some 
ice growth still occurring at 20 mg mL−1, hence care must be 
taken when discussing potency. These results, when taken 
together, suggest that while hydrophobicity is important, the 
spatial segregation of these domains needs to be carefully 
controlled to access IRI active materials. Similar observations 
have been made by copolymerization of vinyl pyrrolidone with 
increasingly hydrophobic units. Homo poly(vinyl pyrrolidone) 
has essentially no activity but incorporation of hydrophobic 
units did increase IRI, albeit at a level which was only just 
above that of PEG.[80]
6.1. Summary
Considering the examples shown above, we propose a rough 
guide for activity considerations when evaluating a new mate-
rial for IRI, especially those which are far less active than AF(G)
Ps Figure 8. We divide the materials into approximately four 
zones, which may align (based on our current understanding) 
with their underlying mechanism of action, as well as magni-
tude of activity. The most active are AF(G)Ps, which function 
at sub 0.1 mg mL−1 levels. There is also significant evidence 
for their selective and strong binding to specific planes of ice, 
which is crucial for their activity. Next, we include those that 
inhibit in the range up to ≈1 mg mL−1, which includes PVA, 
ZrAc, and safranin-O. These materials also shape ice and have 
potent IRI activity, with at least some of their activity arising 
from ice-face binding (if not all). After this, there are the mate-
rials that have no evidence for ice binding (at the moment) but 
are still relatively potent. It is crucial to note that ice binding 
could be occurring, but that it is so weak or transient that 
macro scopic ice shaping is not seen. However, these materials 
are facially amphiphilic with segregation of the domains cru-
cial for their function, enabling them to slow ice growth fully, 
typically in a range <10 mg mL−1. It should be highlighted 
that these are approximate definitions, for example, the highly 
active lysine surfactants of Ben[63] have similar activity to the 
ice binders; hence the need for appreciation that IRI is a con-
tinuum not a binary property. Next is the broad zone of “weak 
inhibitors,” which includes poly(ampholyte)s and hydrophobi-
cally modified polymers, with the upper boundary being the 
activity of PEG. Materials in this range do not appear to bind 
ice to any appreciable extent and in many cases cannot com-
pletely inhibit ice growth over any time period. Nonetheless, 
that does not rule out potential applications, where slowing ice 
is crucial or where high concentrations can be applied.
We feel this (simplistic) display provides a framework to 
discuss new inhibitors, especially those where ultra-high con-
centrations of up to 100 mg mL−1 have been tested,[81] which 
is clearly not a specific effect. There is no suggestion here 
as to which region is worthy of the most study, nor which is 
most promising for a specific application, but rather to help as 
Macromol. Biosci. 2019, 1900082
Figure 7. Poly(ampholyte)s with reported IRI activity. A) Random copoly-
mers of methacrylic acid with aminoethyl methacrylate enhanced by 
addition of methyl methacrylate. Reproduced with permission.[81] Copy-
right 2013, Informa UK Limited. B) Regioregular alternative copolymers 
derived from maleic anhydride and vinyl acetate. Reproduced with per-
mission.[79] Copyright 2017, American Chemical Society.
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a guide in defining materials’ relative function, and to ensure 
that false positives due to simple colligative effects are not mis-
reported in the literature as the field grows.
7. Conclusions
In conclusion, we present a concise evaluation of a range of IRI 
active macromolecules covering several orders of magnitude in 
terms of activity. We show that even though AFGPs and AFPs 
are clearly far more active than synthetic mimics, their role in 
cryopreservation is not just linked to absolute activity but also 
availability, cost, and possible toxicity/immunogenicity. We pro-
pose a grouping of materials into different activity magnitudes 
especially at the lower end of the activity scale (see Section 6.1), 
and highlight that this is not an on/off property but rather a 
continuum. Thus, activity needs to be defined relative to a neg-
ative control, to place it in context. We also propose that the 
less active materials seem to be able to function due to their 
amphipathic structure, and can be more active due to a precise 
interaction with ice.
8. Experimental Section
Ice Recrystallization Inhibition “Splat” Assay: A 10 µL droplet of the 
macromolecule in PBS solution was dropped from 1.4 m onto a glass 
microscope coverslip, which is on top of an aluminum plate cooled to 
−78 °C using dry ice. The droplet freezes instantly upon impact with the 
plate, spreading out and forming a thin wafer of ice. This wafer is then 
placed on a liquid nitrogen cooled cryostage held at −8 °C. The wafer is 
then left to anneal for 30 min at −8 °C. Three micrographs were taken 
of the wafer and the longest grain crystals as well as the total number 
of crystals in the image are counted using ImageJ, and reported as a 
percentage of area compared to PBS control.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
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